Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILON HEALTH, INC.

(AGL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Certain Common Stock of agilon health, inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2021.

10/12/2021 EST

Certain Common Stock of agilon health, inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2021. These Common Stock will be under lockup for 181 days starting from 14-APR-2021 to 12-OCT-2021. Details: Directors, executive officers and certain stockholders will enter into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each of these persons or entities, for a period of 180 days after the date of this prospectus, may not, without the prior written consent of J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, engage in hedging or similar transaction or arrangement, lend or otherwise transfer or dispose of, directly or indirectly, any of our securities that are substantially similar to the securities offered hereby, including but not limited to any options or warrants to purchase shares of our common stock or any securities that are convertible into or exchangeable for, or that represent the right to receive, shares of our common stock or any such substantially similar securities, subject to certain exceptions.


ę S&P Capital IQ 2021
All news about AGILON HEALTH, INC.
12/07AGILON HEALTH : 7 Ways Patients Experience Care Differently Under the agilon health Model
PU
12/06AGILON HEALTH, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
12/06AGILON HEALTH : Preserving Medicare Advantage
PU
11/30AGILON HEALTH : The Many Ways agilon health is Giving Back
PU
11/11agilon health to Participate in Wolfe Research Healthcare Conference
BU
11/11What Military Medicine Taught This Primary Care Physician About Delivering Value-Based ..
PU
11/03Deutsche Bank Lowers Agilon Health's Price Target to $36 From $44, Maintains Buy Rating
MT
11/02Recent Honors Showcase agilon health Business Strength
PU
11/01SVB Leerink Adjusts agilon health's Price Target to $35 from $37, Keeps Outperform Rati..
MT
10/29November 2021 Investor Presentation
PU
More news
Analyst Recommendations on AGILON HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 824 M - -
Net income 2021 -395 M - -
Net cash 2021 1 060 M - -
P/E ratio 2021 -23,2x
Yield 2021 -
Capitalization 9 326 M 9 326 M -
EV / Sales 2021 4,53x
EV / Sales 2022 3,21x
Nbr of Employees 550
Free-Float 98,6%
Chart AGILON HEALTH, INC.
Duration : Period :
agilon health, inc. Technical Analysis Chart | AGL | US00857U1079 | MarketScreener
Technical analysis trends AGILON HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 23,69 $
Average target price 37,33 $
Spread / Average Target 57,6%
EPS Revisions
Managers and Directors
Steven J. Sell President, Chief Executive Officer & Director
Timothy S. Bensley Chief Financial Officer
Ronald A. Williams Chairman
Benjamin Kornitzer Chief Medical & Quality Officer
Girish Venkatachaliah Chief Technology Officer
Sector and Competitors